Oncology Corporate Profile
Nanotherapeutics, Inc. is a privately held biopharmaceutical company with a major focus on developing a diversified proprietary pipeline of products having both biodefense and medical applications. Products under development include biodefense medical countermeasures, CNS, wound healing, addiction and pain, oncology, anti-infectives, vaccines and orthopedics.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|cloretazine||sulfonylhydrazine alkylating agent||Acute Myelogenous Leukemia (AML)||III|
|triapine||ribonucleotide inhibitor||Various cancer types||II|
View additional information on product candidates here »